
Galectin Therapeutics Inc
GALT260.81MMarket Cap
LossP/E TTM
Galectin Therapeutics Inc
GALT Balance Sheet
You can check out the annual or quarterly balance sheets of Galectin Therapeutics Inc here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.
FAQs
Which balance sheet metrics matter most when analyzing GALT stock?
Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.
What is the difference between assets, liabilities, and shareholders' equity?
Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.
What is the difference between current and non-current items?
Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.
How Much Cash Does Galectin Therapeutics Inc Have?
In its most recent quarterly, Galectin Therapeutics Inc had 13.27M in cash and cash equivalents.
How Much Are Galectin Therapeutics Inc's Total Liabilities?
Galectin Therapeutics Inc reported 145.73M in total liabilities as of the latest reported quarter, including 8.03M in current liabilities and 137.70M in non-current liabilities.
What Are Galectin Therapeutics Inc's Total Assets?
As of the latest reported quarter, Galectin Therapeutics Inc's total assets were 19.53M, consisting of 19.44M in current assets and 96.00K in non-current assets.
How Much Shareholders' Equity Does Galectin Therapeutics Inc Have?
Galectin Therapeutics Inc reported -126.19M in total shareholders' equity as of the latest reported quarter.